The Melanoma Research Alliance (MRA), the largest private funder of melanoma research, will hold the second annual Leveraged Finance Fights Melanoma (LFFM) benefit tomorrow at the Summer Garden and Sea Grill at Rockefeller Center in New York City from 6:30-8:30 p.m. Funds raised at the event will support the MRA’s global research program, and tickets are available online at the MRA website.
With recent breakthroughs announced in fighting cancer with immunotherapy, it is timely that the Leveraged Finance community gathers to support the Melanoma Research Alliance. Dr. Jedd Wolchok from Memorial Sloan-Kettering and Dr. Drew Pardoll from Johns Hopkins will be on hand as recipients of the recent $1.5 million LFFM-MRA Academic Industry Partnership Award co-funded by the MRA and Bristol-Myers Squibb. The dramatic results from Dr. Wolchok’s combination trial involving PD-1 and Yervoy, which was supported by LFFM, has been featured prominently in national news coverage.
The hosts for the event are Jeff Rowbottom, from KKR Capital Markets, and Brendan Dillon, from UBS, along with a host committee. Attendees will include leveraged finance professionals from banks, investment houses, law firms, select issuers, and private equity sponsors. As with the inaugural event last year, LCD is a proud sponsor.
Special attendees will include Apollo’s Leon Black, KKR’s Henry Kravis, Oaktree’s Howard Marks, Oak Hill’s Glenn August, and Simpson Thacher Bartlett’s Dick Beattie.
“Melanoma is the fastest growing cancer in the U.S. and worldwide. Nearly 80,000 Americans will be diagnosed in 2013. As Memorial Day weekend and the summer approaches, it is vital to know how to protect yourself and your loved ones against the sun’s harmful rays. With this event, we will raise funds for crucial research, while also raising awareness. Melanoma can usually be defeated if diagnosed early, but if neglected, it can become fatal,” Rowbottom said.
In support of the 2013 event, a group led by Ipreo-Debtdomain, executives from KKR, and other select supporters have made a $250,000 pledge that provides $100 to MRA for every person who has completed a skin check in the last six months or vows to make an appointment within the next three months. The goal is to promote screenings, so any person – not just event participants – can take a pledge on the Ipreo-DebtDomain website.
Roughly 600 professionals attended the inaugural event at the Bryant Park Grill in 2012, with $925,000 raised from 45 sponsors and more than 200 individual donations. 100% of all public donations to the MRA will be used directly to support research programs working toward eliminating suffering and death from melanoma.
More details, including how to purchase tickets, can be found at the Melanoma Research Alliance’s website.
Find LFFM on Facebook and LinkedIn, and see personal stories
here
.
For further information about the LFFM event, donations, and sponsorship opportunities, please Lauren Leiman of the MRA at (202) 336-8938 or lleiman@curemelanoma.org.